Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
34,343,930
-
Shares change
-
+3,569,121
-
Total reported value, excl. options
-
$345,174,620
-
Value change
-
+$34,148,838
-
Put/Call ratio
-
111%
-
Number of buys
-
62
-
Number of sells
-
-33
-
Price
-
$10.05
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2017
123 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q2 2017.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,343,930 shares
of 158,835,667 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include FMR LLC (6,451,713 shares), BRIDGER MANAGEMENT, LLC (4,645,265 shares), BlackRock Inc. (3,202,963 shares), STATE STREET CORP (2,638,683 shares), FRANKLIN RESOURCES INC (2,339,166 shares), VANGUARD GROUP INC (2,046,427 shares), COLUMBUS CIRCLE INVESTORS (1,396,396 shares), JENNISON ASSOCIATES LLC (1,350,881 shares), UBS ASSET MANAGEMENT AMERICAS INC (1,111,297 shares), and SENZAR ASSET MANAGEMENT, LLC (969,300 shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.